Poseida Therapeutics, Inc.

$8.91 0.00% ($0.00)

Get ready to invest

Join the waitlist

About Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company has discovered and are developing a broad portfolio of product candidates in a variety of indications based on its core platforms, including its non-viral piggyBac deoxyribonucleic acid (DNA) Modification System, Cas-CLOVER site-specific gene editing system and nanoparticle- and adeno-associated virus (AAV)-based gene delivery technologies. The Company’s product candidate portfolio includes P-BCMA-101, P-PSMA-101, P-BCMA-ALLO1, P-MUC1C-ALL01, Dual CAR, P-OTC-101 and P-MMUT-101.

Popular Stocks	Price	Change
Apple AAPL	$134.43 1.63%	1.63%
Palantir Technologies PLTR	$23.34 8.44%	8.44%
Nio NIO	$38.48 2.56%	2.56%
Ford Motor F	$12.2 1.61%	1.61%
General Electric GE	$13.44 0.15%	0.15%
Bank Of America BAC	$39.32 0.56%	0.56%
Nuance Communications NUAN	$52.24 1.32%	1.32%
American Airlines AAL	$22.56 1.17%	1.17%
Tesla Motors TSLA	$762.32 6.04%	6.04%
Amc Entertainment AMC	$8.62 1.61%	1.61%